Drug design against a shifting target: A structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

Structure

Volumn 6, Issue 6, 1998, Pages 735-746

  Varghese, Joseph N ^a   Smith, Paul W ^b   Sollis, Steven L ^b   Blick, Tony J ^a   Sahasrabudhe, Anjali ^a   McKimm Breschkin, Jennifer L ^a   Colman, Peter M ^a  

^a CSIRO   (Australia)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antiviral; Drug resistance; Influenza; Inhibitors; Neuraminidase

Indexed keywords

INFLUENZA VIRUS; INFLUENZAVIRUS A;

EID: 0032526697     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(98)00075-6     Document Type: Article

References (61)

1. Lamb, R.A. (1989). Genes and proteins of the influenza virus. In The Influenza Viruses. (Krug, R.M., ed.), pp. 1-87, Plenum, New York.
2. Colman, P.M. (1994). Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci. 3, 1687-1696.
3. Varghese, J.N. (1997). The design of anti-influenza virus drugs from the X-ray molecular structure of influenza virus neuraminidase. In Structure-Based Drug Design: Diseases, Targets, Techniques and Developments, Vol 1 (Veerapandian P., ed.), pp. 459-486, Marcel Dekker, New York.
4. Klenk, E., Faillard, H. & Lempfrid, H. (1955). Über die enzymatische Wirkung von Influenzavirus. Z Physiol. Chem. 301, 235-246.
5. Gottschalk, A. (1957). Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae. Biochim. Biophys. Acta 23, 645-646.
6. Ward, C.W. (1981). Structure of influenza virus hemagglutinin. Curr. Top. Microbiol. Immunol. 94/95, 1-74.
7. Palese, P., Tobita, K., Ueda, M. & Compans, R.W. (1974). Characterisation of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61, 397-410.
8. Burnett F.M. (1947). Mucins and mucoids in relation to influenza virus action. IV. Inhibition by purified mucoid of infection and haemagglutinin with the virus strain WSE. Aust. J. Exp. biol. Med Sci. 26, 381-387.
9. Varghese, J.N., Laver, W.G. & Colman, P.M. (1983). Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature 303, 35-40.22.
10. Colman, P.M., Varghese, J.N. & Laver, W.G. (1983). Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303, 41-44.
11. Burmeister, W.P., Ruigrok, R.W.H. & Cusack, S. (1992). The 2.2 Å resolution crystal structure of influenza B neuraminidase and its complex to sialic acid. EMBO J. 11, 49-56.
12. Meindl, P. & Tuppy, H. (1 969). 2-Deoxy-2,3-dehydrosialic acids. I. Synthesis and properties of 2-deoxy-2,3-dehydro-N-acetylneuraminic acids and their methyl esters. Monatsh. Chem. 100, 1295-1306.
13. Meindl, P., Bodo, G., Palese, P., Schulman, J. & Tuppy, H. (1974). Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology 58, 457-463.
14. Palese, P., Schulman, J.L., Bodo, G. & Meindl, P. (1974). Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluroacetylneuraminic acid (FANA). Virology 59, 490-498.
15. Palese, P. & Schulman, J.L. (1977). Inhibitors of viral neuraminidase as potential antiviral drugs. In Chemoprophylaxis and Virus Infections of the Upper Respiratory Tract, Vol 1. pp. 189-205, CRC Press, Boca Raton, Florida.
16. Varghese, J.N. & Colman, P.M. (1991). Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution. J. mol. Biol. 221, 473-486.
17. Varghese, J.N., McKimm-Breschkin, J.L., Caldwell, J.B., Kortt, A.A. & Colman, P.M. (1992). The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 14, 327-332.
18. von Itzstein, M., et al., & Penn, C.R. (1993). Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423.
19. von Itzstein, M., Wu, W.-Y. & Jin, B. (1994). The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus inhibitor. Carbohydr. Res. 259, 301-305.
20. Woods, J.M., et al., & Penn, C.R. (1993). 4-guanidino-2-4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Ag. Chemother. 37, 1473-1479.
21. Ryan, D.M., Ticehurst, J., Dempsey, M.H. & Penn, C.R. (1994). Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase. Antimicrob. Ag. Chemother. 38, 2270-2275.
22. Thomas, G.P., Forsyth, M., Penn, C.R. & McCauley, J.W. (1994). Inhibition of growth of influenza virus in vitro by 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. Antiviral Res. 24, 351-356.
23. Hayden, F.G., Rollins, B.S. & Madren, L.K. (1994). Anti-influenza activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium. Antiviral Res. 25, 123-131.
24. Hayden, F.G., et al., & Wightman, K. (1997). Efficacy and safety of the neuraminidase inhibitor Zanamivir in the treatment of influenza virus infections. New Engl. J. Med. 337, 874-880.
25. Smith, W., Andrews, C.H. & Laidlaw, P.P. (1933). A virus obtained from influenza patients. Lancet 2, 66-68.
26. McKimm-Breschkin, J.L, Marshall, D. & Penn, C.R. (1994). Phenotypic changes observed in influenza viruses passaged in 4-amino or 4-guanidino-Neu5Ac2en in vitro. Abstracts of the 9th International Conference of Negative Strand Viruses, Estoril, Portugal, p. 260.
27. McKimm-Breschkin, J.L., et al., & Penn. C.R. (1996). Generation and characterisation of variants of the NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. Antimicrob. Ag. Chemother. 40, 40-46.
28. Gubareva, L.V., Bethell, R., Hart, G.J., Penn, C.R. & Webster, R.G. (1995). Characterization of mutants of influenza virus selected with 4-guanidino-Neu5Ac2en. J. Virol. 70, 1818-1827.
29. Blick, T.J., et al., & McKimm-Breschkin, J.L. (1995). Generation and characterization of an influenza virus variant with decreased sensitivity to the neuraminidase specific inhibitor 4-guanidino-Neu5Ac2en. Virology 214, 475-484.
30. McKimm-Breschkin, J.L, et al., & Varghese, J.N. (1998). Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en derivatives. J. Virol. 72, 2456-2462.
31. Staschke K.A., et al., & Laver, W.G. (1995). Molecular basis for resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology 214, 642-646.
32. Hayden, F.G. (1996). Amantidine and rimantidine - clinical aspects. In Antiviral Drug Resistance. (Richmond, D.D., ed.), pp. 69-77, John Wiley, Chichester, UK.
33. Kimberlin D.W., et al., & Whitley R.J. (1995). Antiviral resistance in clinical practice. Antiviral Res. 26, 423-438.
34. Hayden F.G. (1993). Update on antiviral agents and viral drug resistance. In Principles and Practice of Infectious Disease, Vol 2. (Mandell G.L., Douglas R.G. & Bennett J.E., eds), pp. 3-15, Churchill Livingston, New York.
35. Madren L.K., Shipman C. & Hayden F.G. (1995). In vitro inhibitory effects of combinations of anti-influenza agents. Antiviral Chem. Chemother. 6, 109-113.
36. Sollis, S.L., Smith, P.W., Howes, P.D., Cherry, P.C. & Bethell, R.C. (1996). Novel inhibitors of influenza sialidase related to GG167. Synthesis of 4-amino and 4-guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza A virus sialidase. Bioorg. Med. Chem. Lett. 6, 1805-1808.
37. Smith, P.W., et al., & Colman, P. (1996). Novel inhibitors of influenza sialidases related to GG167. Structure-activity, crystallographic and molecular dynamics studies with 4H-pyran-2-carboxylic acid 6-carboxamides. Bioorg. Med. Chem. Lett. 6, 2931-2936.
38. Taylor, N.R., et al., & Varghese, J. (1998). Dihydropyran carboxamides related to GG167. A new series of inhibitors of influenza virus sialidases. Part 2: A crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza types A and B. Bioorg. J. Med. Chem. 41, 798-807.
39. Kim C.U., et al., & Stevens R.C. (1997). Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119, 681-690.
40. Gubareva, L.V., Robinson M.J., Bethell, R. & Webster, R.G., (1997). Catalytic framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. J. Virol. 71, 3385-3390.
41. Varghese, J.N., Epa, V.C. & Colman, P.M. (1995). Three-dimensional structure of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci. 4, 1081-1087.
42. Weiss W., Brown, J.H., Cusack, S., Paulson, J.C., Skehel, J.J. & Wiley, D.C. (1988). Structure of the influenza virus haemagglutinin complexed with its receptor sialic acid. Nature 333, 426-431.
43. Varghese, J.N., Colman, P.M., van Donkelaar, A., Blick, T.J., Sahasrabudhe, A. & McKimm-Breschkin, J.L. (1997). Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases. Proc. Natl Acad. Sci. USA 94, 11808-11812.
44. Webster, R.G., et al., & Laver, W.G. (1987). Antigenic structure and variation in an influenza N9 neuraminidase. J. Virol. 61, 2910-2916.
45. Laver, W.G., Colman, P.M., Webster, R.G., Hinshaw, V.S. & Air, G.M. (1984). Influenza virus neuraminidase with hemagglutinin activity. Virology 137, 314-323.
46. Hausmann, J., Kretzschmar, E., Garten, W. & Klenk, H-.D. (1995). N1 neuraminidase of influenza virus A/FPV/Rostock/34 has haemadsorbing activity. J. Gen. Virol. 76, 1719-1728.
47. Subbarao, K., et al., & Cox, N. (1998). Characterisation of an avian influenza A (H5N1) virus isolated from a child with fatal respiratory illness. Science 279, 393-396.
48. Colman, P.M., et al., & Webster, R.G. (1987). Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature 326, 358-363.
49. Colman, P.M., et al., & Air, G.M. (1989). 3-D structures of influenza virus neuraminidase-antibody complexes. Proc. R. Soc. Lond. B 323, 511-518.
50. Malby, R.L., et al., & Colman, P.M. (1994). The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. Structure 2, 733-746.
51. Colman, P.M. (1997). Virus versus antibody. Structure 5, 591-593.
52. McKimm-Breschkin, J.L., McDonald, M., Blick, T.J. & Colman, P.M. (1996). Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. Virology 225, 240-242.
53. Tantillo, C., et al., & Arnold, E.A. (1994). Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. J. mol. Biol. 243, 369-387.
54. Schock, H.B., Garsky, V.M. & Kuo, L.C. (1996). Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. J. Biol. Chem. 50, 31957-31963.
55. Pettit, S.C., Simsic, J., Loeb, D.D., Everitt, L., Hutchison, CA. & Swanstrom, R. (1991). Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J. Biol. Chem. 266, 14539-14547.
56. Griffiths, J.T., et al., & Kay, J. (1992). Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*procleavage sites. Biochemistry 31, 5193-5200.
57. McKimm-Breschkin, J.L., Caldwell, J.B., Guthrie, R.E. & Korrtt, A.A., (1991). A new method for the purification of influenza virus A virus. J. Virol. Methods 32, 121-124.
58. Baker, A.T., Varghese, J.N., Laver, W.G., Air, G.M. & Colman, P.M. (1987). The three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus. Proteins 1, 111-117.
59. Tulip, W.G., et al., & Colman PM. (1992). Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. J. mol. Biol. 221, 487-497.
60. Brünger, AT. (1992). X-PLOR, Version 3.3: a System for X-ray Crystallography and NMR. Yale University Press, New Haven, CT.
61. Engh, R.A. & Huber, R. (1991). Accurate bond and angle parameters for X-ray protein-structure refinement. Acta Cryst. A 47, 392-400.